ML16323A274

University of California Davis Mcclellan Nuclear Research Center (Mnrc) License Holder Interim Appointment

ML16323A274
Person / Time
Site:	University of California-Davis
Issue date:	10/04/2016
From:	Carter C, Frey W McClellan Nuclear Research Center
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
Download: ML16323A274 (20)

Text

UNIVERSITY OF CALIFORNIA, DAVIS I s.\011 \ H.*\RH:\H,\ * ~.\:-..: r.\ cRt.z McCLELLAN NIJCLE1\R RESE/\RCH CENmR 53J5 PRICE AVENUE, surm 258 MCGLHI.LAN, CALIFORNIA 95652 WESLEY D. FREY n:Lfl'llONE: (916)614-6200 DIRECTOR l'AJC: (916) 614-6257 o:~\111.U; wesfrey@ucdavis.edu October 4, 2016 Document Control Desk U.S. Nuclear Regulatory Commission 1 White Flint North 11555 Rockville Pike Rockville, MD 20852

Subject:

University of California Davis McClellan Nuclear Research Center (MNRC) License Holder Interim Appointment

Reference:

Docket No. 50-607, Facility Operating license No. R-130

Dear Regulators,

In accordance with the UCD/MNRC Technical Specifications Section 6.'7.2C(3), Effective October 1, 2016, Dr. Cameron S. Carter, M.D. will be the Interim Vice Chancellor for Office of Research (MNRC license holder) replacing the current Vice Chancellor Dr. Harris Lewin.

MNRC will submit an additional notification once a permanent selection for Vice Chancellor of Research has been finalized.

Please direct any questions to Dr. Wesley Frey, 916-614-6200 or wesfrey@ucdavis.edu.

Sincerely,

) ./

I II/

1/> .P*>*I

!

//

Wesley D. Frey PhD S. Carter, M.D.

Director, McClellan Nuclear Research Center Vice Chancellor for Research cc: Alexander Adams, U.S. NRC Linh Tran, U.S. NRC

Carter, C.S., curriculum vitae 9/2016 CAMERON S. CARTER, M.D.

CURRICULUM VITAE Home Address: Davis, CA 95618 Birth Place: Perth, Western Australia Citizenship: U.S.A.

E-Mail: cscarter@ucdavis.edu Business Address: Department of Psychiatry and Behavioral Sciences University of California, Davis 2230 Stockton Boulevard Sacramento, CA 95817 Business Phone: 916-734-7783 Business Fax: 916-734-8750 EDUCATION and TRAINING UNDERGRADUATE 1973-1979 University of Western Australia School of Medicine, MBBS (MD, Medicine) 1975 National Health and Medical Research Council Fellow. Twelve months research in the Department of Anatomy and Human Biology, University of Western Australia Bachelor of Medical Science (honors). Functional Neuroanatomy 1972 Matriculated to University of Western Australia with Commonwealth Scholarship POSTGRADUATE 1988-1989 Clinical Research Fellow in Psychiatry, U.C. Davis Medical Center, Sacramento, California 1985-1989 Psychiatry Resident University of California at Davis Medical Center and the Veterans Administration Medical Center at Martinez, California 1982 Resident Medical Officer, Flinders Medical Center, Adelaide, South Australia 1981-1982 Intern, Flinders Medical Center, Adelaide, South Australia APPOINTMENTS and POSITIONS ACADEMIC 2014-present Director, Behavioral Health Center of Excellence, University of California, Davis 2011-present Director, Center for Neuroscience, University of California, Davis 2009-2011 Interim Director, Center for Neuroscience, University of California at Davis 2006-2011 Chair, Graduate Group in Clinical and Translational Research, University of California, Davis 2006-present Director, Schizophrenia Research and Education Program, University of California, Davis 2006-present Administrative Chair in Schizophrenia Research, Department of Psychiatry & Behavioral Sciences, University of California, Davis 2004-present Director, EDAPT (Early Diagnosis and Preventive Treatment) Clinic, UC Davis Medical Center 2003-present Director, Imaging Research Center, University of California, Davis 2003-present Professor of Psychiatry and Psychology, University of California, Davis

Carter, C.S., curriculum vitae 9/2016 2003-2010 Adjunct Professor of Psychiatry, University of Pittsburgh 2003 Associate Professor of Psychiatry, Psychology, Neuroscience and Radiology, University of Pittsburgh 2001-2003 Director, Cognitive and Affective Neuroimaging, UPMC MR Research Center, and Cognitive and Affective Neuroscience Program, Department of Psychiatry, University of Pittsburgh 1999-2003 Associate Professor of Psychiatry, Psychology and Neuroscience, University of Pittsburgh 1998-2003 Associate Professor of Psychiatry and Psychology, University of Pittsburgh 1998-2003 Co-Director Clinical Cognitive Neurosciences Laboratory, University of Pittsburgh 1997-2003 Associate Director, Clinical Services Core, Conte Center for Neuroscience and Mental Disorders, Department of Psychiatry, University of Pittsburgh.

Director, Ambulatory Services, STEP (First Episode Psychosis) Clinic, WPIC 1995-1996 Associate Director, Office of Medical Student Education, Department of Psychiatry, University Pittsburgh, Western Psychiatric Institute and Clinic 1993-1999 Assistant Professor of Psychiatry, University of Pittsburgh, Western Psychiatric Institute and Clinic, Pittsburgh, PA Attending Psychiatrist, Schizophrenia Treatment and Research Center, Western Psychiatric Institute and Clinic, Pittsburgh, PA 1991-1993 Director, Medical Student Education, Department of Psychiatry, University of California at Davis 1989-1991 Assistant Director of Residency Training, Department of Psychiatry, University of California at Davis 1989-1993 Assistant Professor of Psychiatry, University of California, Davis NON-ACADEMIC 1987-1989 Psychiatrist, Crisis Unit, Contra Costa County Division of Mental Health and Substance Abuse, Merrithew Memorial Hospital, Martinez, California 1984-1985 General Practice, Tacoma, Washington 1982-1984 General Practice, Elizabeth, South Australia CERTIFICATION and LICENSURE SPECIALTY CERTIFICATION Certified in Psychiatry by the American Board of Psychiatry and Neurology, June 1992, ABPN# 35765 MEDICAL or OTHER PROFESSIONAL LICENSURE California License A43389 MEMBERSHIPS in PROFESSIONAL and SCIENTIFIC SOCIETIES American Psychiatric Association, 1989-present Society for Biological Psychiatry, 1995-present Society for Cognitive Neuroscience, 1993-present Society for Neuroscience, 1999-present Organization for Human Brain Mapping, 200 I-present American College ofNeuropsychopharmacology, Member 2003-present, Fellow 2010-present 2

Carter, C.S., curriculum vitae 9/2016 HONORS Best Doctors in Sacramento, Sacramento Magazine 2013-Present Thompson-Reuters Highly Cited Scholar (top 1% in Psychiatry and Psychology) 2014 Mental Health Board of Sacramento, "Mental Health Hero" 2014 Dean's Award for Excellence in Community Engagement, 2008 NARSAD Distinguished Investigator Award, 2007 Dean's Excellence in Mentoring Award, UC Davis School of Medicine, 2006 Elected to the American College ofNeuropsychopharmacology, 2003 NARSAD Klerman Award for Outstanding Clinical Research Achievement, 2001 NIMH Independent Scientist Career Award (K02), 2001-2006 Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, 2001-2006 Honorable Mention, Klerman Award for Outstanding Clinical Research by a NARSAD Young Investigator, 1998 NARSAD Young Investigator Award, 1997 NIMH Mentored Scientist Development Award for Clinicians (KOS), 1996-2001 NARSAD Young Investigator Award, 1994 NIMH NCDEU Young Investigator Travel Award, 1993 Northern California Psychiatric Association Resident Recognition Award for Clinical Excellence in Psychiatry, 1989 Friendly Societies Prize for Medicine, 1973 Convocation Prize for Medicine, 1973 NATIONAL and INTERNATIONAL COMMITTEES Member, Scientific Council-Brain and Behavior Foundation (NARSAD), 2005-Present Deputy Editor, Biological Psychiatry, 2006-present Founding Editor-in-Chief Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2015-present Scientific Advisory Committee, Organization for Human Brain Mapping Annual Meeting, 200 I-present Editorial Board, Biological Psychiatry 2000-2006 Editorial Board Neuropsychopharmacology 2003-present Editorial Board, Schizophrenia Bulletin 2005-2009 Editorial Board, Psychiatry Research: Neuroimaging 2005-present Charter Member IRG IFCN 7 Learning and Memory LAM), 2002-2005 Ad Hoc Reviewer, VA Merit Program and National Science Foundation, 2000-present Ad Hoc Member IRG BDCN6, 2001 Chair ZMHl-Nllli-Q 06, SEP Translational Research Center Awards, 2003-2006 Charter Member, NPAS Study Section, 2008-2011 Member, ZMHl ERB-S (03), Special Emphasis Panel, Conte Centers for Schizophrenia, National Institutes of Mental Health, 2004-2006 Organizer, New Advances Conference, MATRICS, NIMH, 2004 Member, Neuropharmacology Committee, MA TRI CS, NIMH, 2004 3

Carter, C.S., curriculum vitae 9/2016 Advocacy Group Committee, American College ofNeuropsychopharmacology, 2004-present, Chair 2010-2011 Member, Ad Hoc Committee, Board of Scientific Counselors, Director's Office, National Institutes of Mental Health, 2005, 2006 PUBLICATIONS Citations 47,532; H Factor 95; ilO -index 228 REFEREED ARTICLES

1. Carter CS, Bearden CE, Bullmore ET, Geschwind DH, Glahn DC, Gur RE, Meyer-Lindenberg A, Weinberger DR (2016).

Enhancing the Informativeness and Replicability oflmaging Genomics Studies. Biological Psychiatry. (In Press).

2. Solomon M, McCauley JB, Iosif AM, Carter CS, Ragland JD (2016). Cognitive control and episodic memory in adolescents with autism spectrum disorders. Neuropsychologia. 2016 Aug; 89: 31-41. doi: 10.1016/j.neuropsychologia.2016. 05. 013. Epub 2016 May 13. PMID: 27184119

3. Carrion RE, Comblatt BA, Burton CZ, Tso IF, Auther AM, Adelsheim S, Calkins R, Carter CS, Niendam T, Sale TG, Taylor SF, Mcfarlane WR (2016). Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. Am J Psychiatry. 2016 Jul I :appiajp201615121565. Epub ahead of print. PMID: 27363511

4. Barch DM, Carter CS (2016). Functional and Structural Brain Connectivity in Psychopathology. Biological Psychiatry:

Cognitive Neuroscience and Neuroimaging. Volume 1, issue 3, May 2016, Pages 196-198.

5. Poppe AB, Barch DM, Carter CS, Gold JM, Ragland JD, Silverstein SM, MacDonal AW 3rd (2016). Reduced Frontoparietal Activity in Schizophrenia Is Linked to a Specific Deficit in Goal Maintenance: A Multisite Functional Imaging Study.

Schizophrenia Bulletin. 2016Sep;42(5):1149-57. doi: J0.1093/schbul/sbw036. Epub 2016 Apr 8. PMID: 27060129

6. Minzenberg MJ, Lesh TA, Niendam TA, Cheng Y, Carter CS (2016). Conflict-Related Anterior Cingulate Functional Connectivity Is Associated With Past Suicidal Ideation and Behavior in Recent-Onset Psychotic Major Mood Disorders.

J Neuropsychiatry Clin Neurosci. 2016 Apr 8:appineeuropsychl 5120422. Epub ahead of print. PMID: 27056021

7. Carter CS, Lesh TA, Barch DA (2016). Thresholds, Power, and Sample Sizes in Clinical Neuroimaging. Biological Psychiatry:

Cognitive Neuroscience and Neuroimaging. Volume 1, Issue 2, March 2016, Pages99-100.

8. Girgis RR, Van Snellenberg JX, Glass A, Kegeles LS, Thompson JL, Wall M, Cho RY, Carter CS, Slifstein M, Abi-Dargham A, Lieberman JA (2016). A proof-of-concept, randomized controlled trial ofDAR-0100A, a dopamine-I receptor agonist, for cognitive enhancement in schizophrenia. J Psychopharmacol. 2016 May;30(5):428-35. doi: 10.117710269881116636120.

Epub 2016 Mar 10. PMID: 26966119

9. Lynch S, Mcfarlane WR, Joly B, Adelsheim S, Auther A, Comblatt BA, Migliorati M, Ragland JD, Sale T, Spring E, Calkins R, Carter CS, Jaynes R, Taylor SF, Downing D (2016). Early Detection, Intervention and Prevention of Psychosis Program:

Community Outreach and Early Identification at Six U.S. Sites. Psychiatric Services. 2016May1;67(5):510-6. doi:

JO.J 176/appi.ps.201300236. Epub 2016 Jan 14.

10. Ragland JD, Ranganath C, Phillips J, Boudewyn MA, Kring AM, Lesh TA, Long DL, Luck SJ, Niendam TA, Solomon M, Swaab TY, Carter CS (2015). Cognitive Control of Episodic Memory in Schizophrenia: Differential Role ofDorsolateral and Bentrolateral Preftontal Cortext. Front Hum Neurosci. 2015 Nov 1O;9:604. doi: 10. 3389/fnhum. 2015. 00603. eCollecton 2015.

11. Ragland JD, Ranganath C, Hanns MP, Barch DM, Gold JM, Layher E, Lesh TA, MacDonald AW 3rd, Niendam TA, Phillips J, Silverstein SM, Yonelinas AP, Carter CS (2015). Functional and Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia: A Functional Magnetic Resonance Imaging Study of the Relational and Item-Specific Encoding Task. JAMA Psychiat1y. 72(9):909-16.

12. Solomon M, Ragland JD, Niendam TA, Lesh TA, Beck JS, Matter JC, Frank MJ, Carter CS [Epub 2015]. Atypical Leaming in Autism Spectrum Disorders: A Functional Magnetic Resonance Imaging Study of Transitive Inference. J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):947-55.

13. Minzenberg MJ, Lesh T, Niendam T, Yoon JH, Cheng Y, Rhoades RN, Carter CS. (2015) Frontal Motor Cortex Activity During Reactive Control Is Associated With Past Suicidal Behavior in Recent-Onset Schizophrenia. Crisis. 2015 Sep;36(5):363-70.

4

Carter, C.S., curriculum vitae 9/2016

14. Phillips RC, Salo T, Carter CS. (2015) Distinct neural correlates for attention lapses in patients with schizophrenia and healthy participants. Front Hum Neurosci. 2015 Oct 6;9:502.

15. Lopez-Garcia P, Lesh TA, Salo T, Barch DM, MacDonald AW 3rd, Gold JM, Ragland JD, Strauss M, Silverstein SM, Carter CS. (2015) The neural circuitry supporting goal maintenance during cognitive control: a comparison of expectancy AX-CPT and dot probe expectancy paradigms. Cogn Affect Behav Neurosci. 2015 Oct 22. Epub ahead of print.

16. Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald AW 3rd, Ragland JD, Silverstein SM, Godwin D, Barch DM. (2015) Evidence for Accelerated Decline of Functional Brain Network Efficiency in Schizophrenia. Schizophr Bull. 2015 Oct 15. pii: sbv 148. Epub ahead of print.

17. Sheffield JM, Repovs G, Harms MP, Carter CS, Gold J, MacDonald III AW, Ragland JD, Silverstein S, Godwin, D, Barch DM (2015). Evidence for accelerated decline of functional network efficiency in schizophrenia. Schizophrenia Bulletin. Oct 15. pii:

sbv148. Epub ahead ofprint.

18. Carter CS (2015). Rectifying disordered brain dynamics to improve cognition in schizophrenia. Proceedings of the National Academy of Sciences of the United States ofAmerica. 2015 Jul 28; 112(30): 9152-3. Doi: 10.1073/pnas.1511091112. Epub 2015 Jul 8.

19. Minzenberg MJ, Yoon JH, Cheng Y, Carter CS (2015). Sustained Modafinil Treatment Effects on Control-Related Gamma Oscillatory Power in Schizophrenia. Neuropsychopharmacology. 2015 Sep 2. Doi: 10.1038/npp.2015. 2 71. Epub ahead of print.

20. Minzenberg MJ, Lesh TA, Niendam TA, Yoon JH, Cheng Y, Rhoades RN, Carter CS (2015). Control-Related Frontal-Striatal Function is Associated with Past Suicidal Ideation and Behavior in Patients with Recent-Onset Psychotic Major Mood Disorders.

Journal ofAffective Disorders. 188:202-9.

21. Carter CS, Ragland JD, Niendam TA, Lesh TA, Frank MJ, Beck JS, Matter JC (2015). Atypical Leaming in Autism Spectrum Disorders: An fMRI Study of Transitive Inference. Journal of the American Academy of Child and Adolescent Psychiatry.

54(11):947-55.

22. Phillips RC, Salo T, Carter CS (2015). Distinct neural correlates for attention lapses in patients with schizophrenia and healthy participants. Frontiers in Human Neuroscience. 6;9:502.

23. Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald III AW, Ragland JD, Silverstein SM, Godwin D, Barch DM (2015). Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia.

Neuropsychologia. 73:82-93.

24. Swaab TY, Carter CS, Long D, Traxler M, Lesh TA, Mangun GR, Boudewyn MA, Shruti D (2015). Sensitivity to Referential Ambiguity in Discourse: the Role of Attention, Working Memory and Verbal Ability. Journal of Cognitive Neuroscience.

27(12):2309-23.

25. Jarskog LF, Lowy MT, Grove RA, Keefe RSE, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csemansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurell M, Lieberman JA, Marder SR, Maruff P, McMahon RP, Seidman LJ, Peykamian MA (2015). A Phase II study ofa histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Reseqrch. 164(1-3): 136-42.

26. Kappenman ES, Luck SJ, Kring AM, Lesh TA, Mangun GR, Niendam TA, Ragland JD, Ranganath C, Solomon M, Swaab TY, Carter CS (2014). Electrophysiological evidence for impaired control of motor output in schizophrenia. Cerebral Cortex.

Jan 24. pii: bhu329. Epub ahead of print.

27. Poppe AB, Carter CS, Minzenberg MJ, MacDonald AW 3rd (2014). Task-based functional connectivity as an indicator of genetic liability. Schizophrenia Research. 162(1-3): 118-23.

28. Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JHY, Minzenberg MJ, Ragland JD, Solomon M, Carter CS (2014). A Multi-modal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia. Jama Psychiatry.

72(3):226-3.

29. Solomon M, Frank MJ, Ragland JD, Smith AC, Niendam TA, Lesh TA, Grayson DS, Beck JS, Matter JC, Carter CS (2014).

Feedback-Driven Trial-by-Trial Leaming in Autism Spectrum Disorders. American Journal of Psychiatry. 2014 Aug 26.

Epub ahead of print.

30. Fisher M, Loewy R, Carter CS, Lee A, Ragland JD, Niendam TA, Schlosser D, Pham L, Miskovish T, Vinogradov S (2014).

Neuroplasticity-Based Auditory Training Via Laptop Computer Improves Cognition in Young Individuals With Recent Onset Schizophrenia. Schizophrenia Bulletin 2014 Jan 20. Epub ahead of print.

5

Carter, C.S., curriculum vitae 9/2016

31. Minzenberg MJ, Lesh TA, Niendam TA, Yoon JH, Rhoades RN, Carter CS (2014). Frontal cortex control dysfunction related to long-term suicide risk in recent-onset schizophrenia. Schizophrenia Research Aug; 157(1-3): 19-25.

32. Mote, J, Minzenberg MJ, Carter CS, Kring AM (2014). Deficits in anticipatory but not consummatory pleasure in people with recent-onset schizophrenia spectrum disorders. Schizophrenia Research. 159(1): 76-9.

33. Minzenberg MJ, Yoon JH, Cheng YA, Carter CS (2014). Modafinil Effects on Middle-Frequency Oscillatory Power During Rule Selection in Schizophrenia. Neuropsychopharmacology. Epub ahead of print.

34. Mcfarlane WR, Levin B, Travis L, Lucas FL, Lynch S, Verdi M, Williams D, Adelsheim S, Calkins R, Carter CS, Comblatt B, Taylor SF, Author AM, McFarland B, Melton R, Migliorati M, Niendam T, Ragland JD, Sale T, Salvador M, Spring L (2014).

Clinical and functional outcomes after 2 years in the Early Detection and Intervention for the Prevention of Psychosis multisite effectiveness trial. Schizophrenia Bulletin. 41(1):30-43.

35. Caldwell JG, Krug MK, Carter CS, Minzenberg MJ (2014). Cognitive Control in the Face ofFear: Reduced Cognitive-Emotional Flexibility in Women with a History of Child Abuse. Journal ofAggression, Maltreatment & Trauma, 23:5, 454-472.

36. Fassbender C, Scangos K, Lesh TA, Carter CS (2014). RT Distributional Analysis of Cognitive Control-Related Brain Activity in First Episode Schizophrenia. Cognitive, Affective & Behavioral Neuroscience 14(1): 175-88.

37. Pakyurek M, Yamal R, Carter CS (2013). Treatment of psychosis in children and adolescents: a review. Adolesc Med State Art Rev Aug;24(2):420-32, ix.

38. Lesh TA, Westphal AJ, Niendam TA, Yoon JH Minzenberg MJ, Ragland JD, Solomon M, Carter CS (2013). Proactive and reactive cognitive control and dorsolateral prefrontal cortex dysfunction in first episode schizophrenia. Neuroimage: Clinical 2:590-599.

39. Swaab T, Boudewyn M, Long D, Luck S, Kring A, Ragland JD, Ranganath C, Lesh TA, Niendam TA, Solomon M, Mangun GR, Carter CS (2013). Spared and Impaired Spoken Discourse Processing in Schizophrenia: Effects of Local and Global Language Context. Journal ofNeuroscience 33(39):15578-87.

40. Niendam TA, Lesh TA, Yoon J, Westphal AJ, Hutchison N, Ragland JD, Solomon M, Minzenberg M, Carter CS (2013).

Impaired context processing as a potential marker of psychosis risk state. Psychiatry Research 221(1):13-20.

41. Carter CS, Bullmore, E.T., Harrison, P. Is there a Flame in the Brain in Psychosis? Biological Psychiatry 75(4):258-9.

42. Minzenberg MJ, Gomes GC, Yoon JH, Swaab TY, Carter CS (2013). Disrupted action monitoring in recent-onset psychosis patients with schizophrenia and bipolar disorder. Psychiatry Research: Neuroimaging 221(1):114-21.

43. Moore H, Geyer, MA, Carter CS, Barch DM (2013). Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models. Neuroscience &

Biobehavioral Reviews 37(9):2087-91.

44. Sheffield JM, Gold JM, Strauss ME, Carter CS, Macdonald AW 3rd, Ragland JD, Silverstein SM, Barch DM (2013). Common and specific cognitive deficits in schizophrenia: relationships to function. Cognitive, Affective & Behavioral Neuroscience.

Epub ahead of print.

45. Tryon MS, Carter CS, Decant R, Laugero KD (2013). Chronic stress exposure may affect the brain's response to high calorie food cues and predispose to obesogenic eating habits. Physiology & Behavior 120:233-42.

46. Salo RE, Fassbender C, losif AM, Ursu S, Leamon MH, Carter CS (2013). Predictors ofmethamphetamine psychosis: History of ADHD-relevant childhood behaviors and drug exposure. Psychiatry Research 210(2):529-35.

47. Solomon M, Yoon JH, Niendam TA, Ragland JD, Lesh TA, Fairbrother W, Carter CS (2013). The development of the neural substrates of cognitive control in adolescents with autism spectrum disorders. Biological Psychiatry 76(5):412-21.

48. Ravizza SM, Solomon M, Ivry RB, Carter CS (2013). Restricted and repetitive behaviors in autism spectrum disorders: The relationship of attention and motor deficits. Development and Psychopathology 25(3): 773-84.

49. Strauss ME, McLouth CJ, Barch DM, Carter CS, Gold JM, Luck SJ, Macdonald AW 3rd, Ragland JD, Ranganath C, Keane BP, Silverstein SM (2013). Temporal Stability and Moderating Effects of Age and Sex on CNTRaCS Task Performance.

Schizophrenia Bulletin 40(4):835-44.

50. Paz-Alonso PM, Ghetti S, Ramsay I, Solomon M, Yoon J, Carter CS, Ragland JD (2013). Semantic processes leading to true and false memory formation in schizophrenia. Schizophrenia Research 147(2-3):320-5.

6

Carter, C.S., curriculum vitae 9/2016

51. Fulford D, Niendam TA, Floyd EG, Carter CS, Mathalon DH, Vinogradov S, Stuart BK, Loewy, RL (2013). Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophrenia Research 147(1):125-31.

52. Richard AE, Carter CS, Cohen JD, Choy RY (2013). Persistence, diagnostic specificity and genetic liability for context-processing deficits in schizophrenia. Schizophrenia Research 147(1):75-80.

53. Owoso A, Carter CS, Gold JM, Macdonald AW, Ragland JD, Silverstein SM, Strauss ME, Barch DM (2013). Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different. Psychological Medicine 25: 1-11.

54. Miller M, Bales KL, Taylor SL, Yoon J, Hostetler CM, Carter CS, Solomon M (2013). Oxytocin and Vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms. Autism Research 6(2):91-102.

55. Yoon JH, Minzenberg MJ, RaoufS, D'Esposito, Carter CS (2013). Impaired prefrontal-Basal Ganglia functional connectivity and substantial nigra hyperactivity in schizophrenia. Biological Psychiatry 74(2):122-9.

56. Mcfarlane WR, Cook WL, Downing D, Ruff A, Lynch S, Adelsheim S, Calkins R, Carter CS, Cornblatt B, and Milner K (2012). Early Detection, Intervention, and Prevention of Psychosis Program: Rationale, Design, and Sample Description. Adolescent Psychiatry 2(2) 112-124.

57. Mcfarlane WR, Cornblatt B, Carter CS (2012). Early Intervention in Psychosis: Rationale, Results and Implications for Treatment of Adolescents at Risk. Adolescent Psychiatry 2:2 Pp: 125-139.

58. Pakyurak M, Yarnal R, Carter CS (2012). Treatment of Psychosis in Children and Adolescents- A Review. Journal of Pediatrics. 24(2):420-32, ix.

59. Boudewyn MA, Carter CS, Swaab TY (2012). Cognitive control and discourse comprehension in schizophrenia. Schizophrenia Research Treatment. 2012:484-502.

60. Krug MK, Carter CS (2012). Proactive and reactive control during emotion interference and its relationship to trait anxiety.

Brain Research 1481:13-36.

61. Minzenberg MJ, Yoon JH, Soosman SK, Carter CS (2012). Excessive Contralateral Motor Overflow in Schizophrenia Measured by fMRI. Psychiatry Research: Neuroimaging 202(1):38-45.

62. Yoon JH, Nguyen DV, McVay LM, Deramo P, Minzenberg MJ, Ragland JD, Niendam T, Solomon M, Carter CS (2012).

Automated classification offMRI during cognitive control identifies more severely disorganized subjects with schizophrenia.

Schizophrenia Research 135(1-3):28-33.

63. Niendam TA, Laird AR, Ray KL, Dean YM, Glahn DC, Carter CS (2012). Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cognitive Affective Behavior in Neuroscience 12(2):241-68.

64. Keane BP, Silverstein SM, Barch DM, Carter CS, Gold JM, Kovacs I, MacDonald AW 3rd, Ragland JD, Strauss ME (2012).

The spatial range ofcontour integration deficits in schizophrenia. Experimental Brain Research 220(3-4);251-9.

65. Carter CS (2012). Neuroeconomics: sharpened tools of value for clinical cognitive and affective neuroscience. Biological Psychiatry 72(2):82-3.

66. Minzenberg MJ, Carter CS (2012). Developing treatments for impaired cognition in schizophrenia. Trends in Cognitive Science 16:35-42.

67. Millan MJ, Agid Y, Brune M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, Derubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, Joels M. Mansuy IM, Meyer-Lindenberg A, Murphy D, Rolls E, Saletu B, Spedding M, Sweeney J, Whittington M, Young LJ (2012). Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews/Drug Discovery 11:141-168.

68. Barch D M, Carter CS, Dakin SC, Gold J, Luck SJ, MacDonald A 3rd, Ragland JD, Silverstein S, Strauss ME (2012). The clinical translation of a measure of gain control: the contrast-contrast effect Schizophrenia Bulletin 38: 135-143.

69. Gold JM, Barch DM, Carter CS, Dakin S, Luck SJ, MacDonald AW 3rd, Ragland JD, Ranganath C, Kovacs I, Silverstein SM, Strauss M (2012). Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophrenia Bulletin 38: 144-152.

70. Henderson D, Poppe AB, Barch DM, Carter CS, Gold JM, Ragland JD, Silverstein SM, Strauss ME, MacDonald AW 3rd (2012). Optimization of a goal maintenance task for use in clinical applications. Schizophrenia Bulletin 38: 104-113.

7

Carter, C.S., curriculum vitae 9/2016

71. Ragland JD, Ranganath C, Barch DM, Gold JM, Haley B, MacDonald AW 3rd, Silverstein SM, Strauss ME, Yonelinas AP, Carter CS (2012). Relational and item-specific encoding (RISE): Task development and psychometric characteristics.

Schizophrenia Bulletin 38: 114-124.

72. Silverstein SM, Keane BP, Barch DM, Carter CS, Gold JM, Kovacs I, Macdonald A 3rd, Ragland JD, Strauss ME (2012).

Optimization and validation of a visual integration test for schizophrenia research. Schizophrenia Bulletin 38: 125-134.

73. Ragland JD, Blumenfeld RS, Ramsay IS, Yonelinas A, Yoon J, Solomon M, Carter CS, Ranganath C (2012). Neural correlates of relational and item-specific encoding during working and long-term memory in schizophrenia. Neurolmage 59: 1712-1726.

74. Carter CS, Minzenberg M, West R, MacDonald A 3rd (2012). CNTRICS imaging biomarker selections: Executive control paradigms. Schizophrenia Bulletin 38:34-42.

75. Solomon M, Frank MJ, Smith A, Ly S, Carter CS (2011). Transitive inference in adults with autism spectrum disorders.

Cognitive Affective Behavioral Neuroscience 11 (3):437-439.

76. Carter CS, Barch DM; CNTRICS Executive Committee (2012). Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: Biomarkers recommended for further development. Schizophrenia Bulletin 38:26-33.

77. Solomon M, Smith AC, Frank MJ, Ly S, Carter CS (2011). Probabilistic reinforcement learning in adults with Autism Spectrum Disorders. Autism Research 4: 109-120.

78. Solomon M, Olsen E, Niendam T, Ragland JD, Yoon J, Minzenberg M, Carter CS (2011). From lumping to splitting and back again: Atypical social and language development in individuals with clinical-high-risk for psychosis, first episode schizophrenia, and autism spectrum disorders. Schizophrenia Research 13: 146-151.

79. Solomon M, Miller M, Taylor SL, Hinshaw SP, Carter CS (2012). Autism symptoms and internalizing psychopathology in girls and boys with autism spectrum. Journal ofAutism and Developmental Disorders 42:48-59.

80. Carter CS, Barch DM, Bullmore J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T (2011 ). Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: Developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biological Psychiatry 70: 7- 12.

81. Fomito A, Yoon J, Zalesky A, Bullmore ET, Carter CS (2011 ). General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biological Psychiatry 70:64-72.

82. Mayda AB, Westphal A, Carter CS, Decarli C (2011). Late life cognitive control deficits are accentuated by white matter disease burden. Brain 134:1673-1683.

83. Walsh BJ, Buonocore MH, Carter CS, Mangun GR. (2011). Integrating conflict detection and attentional control mechanisms.

Journal of Cognitive Neuroscience, 23:2211-2221.

84. Minzenberg MJ, Yoon JH, Carter CS (2011). Modafinil modulation of the default mode network. Psychopharmacology 215:23-31.

85. Lesh TA, Niendam T, Minzenberg M, Carter CS (2011). Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning.

Neuropsychopharmacology 36:316-3 8.

86. Forster SE, Carter CS, Cohen JD, Cho RY (2011). Parametric manipulation of the conflict signal and control-state adaptation.

Journal of Cognitive Neuroscience 23:923-35.

87. Ursu S, Kring AM, Gard M. Minzenberg MJ, Yoon JH, Ragland JD, Solomon M, Carter CS (2011). Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia. American Journal ofPsychiatry 168:276-285.

88. Minzenberg MJ, Fir! A, Yoon J, Gomes G, Rienking C, Carter CS (2010). Gamma oscillatory power is impaired during cognitive control independent of medication status in first episode schizophrenia. Neuropsychopharmacology 35:2590-9.

89. Hannula DE, Ranganath C, Ramsay IS, Solomon M, Yoon J, Niendam TA, Carter CS, Ragland JD (2010). Use of Eye Movement Monitoring to Examine Item and Relational Memory in Schizophrenia. Biological Psychiatry 68:610-6.

90. Krug MK and Carter CS (2010). Adding fear to conflict: a general purpose cognitive control network is modulated by trait anxiety. Cognitive Affective and Behavioral Neuroscience 10:357-71.

91. Ravizza S, Maua KC, Long D, Carter CS (2010). The impact of context processing deficits on task switching in schizophrenia.

Schizophrenia Research 116:274-9.

8

Carter, C.S., curriculum vitae 9/2016

92. Yoon JHY, Maddock RJ, Rokem A, Minzenberg M, Ragland JD and Carter CS (2010). GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation specific surround suppression. Journal ofNeuroscience. 2010 Mar 1O;30(10): 3777-81.

93. Stoddard J, Niendam T, Hendren R, Carter CS, Simon TJ (2010). Attenuated positive symptoms of psychosis in adolescents with chromosome 22ql 1.2 deletion syndrome. Schizophrenia Research 118:118-21.

94. Van Veen V, Krug M, Schooler J, Carter CS (2009). Neural activity predicts attitude change in cognitive dissonance. Nature Neuroscience. 2009Nov;12(11): 1469-74.

95. Wendelken C, Ditterich J, Bunge SA, Carter CS (2009). Stimulus and response conflict processing during perceptual decision-making. Cognitive, Affective, & Behavioral Neuroscience. 9(4) 434-747.

96. Cho RY, Orr JM, Cohen JD Carter CS (2009). Generalized signaling for cognitive control. Evidence from post-conflict and post-error performance adjustments. J Exp Psycho/ Hum Percept Perform. 35(4): 1161-77.

97. Yoon JH, Rokem AS, Silver MA, Minzenberg MJ, Ursu S, Ragland JD, Carter CS (2009). Diminished orientation-specific surround suppression of visual processing in schizophrenia. Schizophrenia Bulletin. 35(6): 1078-84

98. Solomon M, OzonoffSJ, Ursu S, Ravizza S, Cummings N, Ly S, Carter CS (2009). The neural substrates of cognitive control deficits in autism spectrum disorders. Neuropsychologia 47(12):2515-26

99. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC (2009). Meta-analysis of 41 functional neuroimaging studies of executive function reveals dysfunction in a general-purpose cognitive control system in schizophrenia. Archives of General Psychiatry Aug;66(8):81 l-22 ..

100.Minzenberg MM and Carter CS (2009). The Neuroschemistry of Rule Use. Biological Psychiatry 15(66): 306.

101.Corbett BA, Carmean V, Ravizza S, Wendelken C, Henry ML, Carter C, Rivera SM (2009). A functional and structural study of emotion and face processing in children with autism. Psychiatry Research: Neuroimaging 173(3) 196-205.

102.Ursu S, Carter CS (2009). An initial investigation of the orbitofrontal cortex hyperactivity in obsessive-compulsive disorder:

exaggerated representations of anticipated aversive events? Neuropsychologia. Aug; 47 (10): 2145-8.

103.Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Andreasen NC, Brady KT, Brent DA, Brzustowicz L, Carter CS, Eisenberg L, Goldman H, JavittDC, Leibenluft E, Liberman JA, Milrod B, Oquendo MA, Rosenbaum JF, Rush AJ, Siever LJ, Suppes P, Weissman MM, Roy MD, Scully JH Jr, Yager J (2009). Conflict of interest - an issue for every psychiatric.

American Journal of Psychiatry 166(3):274.

104. Carter CS, Krug MK (2009). The functional neuroanatomy of dread: Functional magnetic resonance imaging insights into generalized anxiety disorder and its treatment. American Journal ofPsychiatry 166(3): 263-265.

105. Bhangoo RK, Carter CS (2009). Very early interventions in psychotic disorders. Psychiatric Clinics of North America 32(1):81-94.

106. Carter CS (2009). The ups and downs ofemotion regulation. Biological Psychiatry 65(5):359-360.

107. Ursu S, Clark KA, Aizenstein HJ, Stenger VA, Carter CS (2009). Conflict-related activity in the caudal anterior cingulated cortex in the absence of awareness. Biological Psychology 80(3):279-286.

108. Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R (2009). Selecting paradigms from cognitive neuroscience for translation to use in clinical trials: Proceedings of the Third CNTRICS Meeting. Schizophrenia Bulletin 35(1): 109-114.

109. Aizenstein, H.J., Butters, M.A., Wu, M., Mazurkewicz, L. M., Stenger, V. A., Gianaros, P. J., Becker, J.T., Reynolds, C.F. III, Carter CS (2009). Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena.

American Journal of Geriatric Psychiatry 17(1):30-42.

110. Barch DM, Braver TS, Carter CS, Poldrack RA, Robbins TW (2009). CNTRICS Final Task Selection: Executive Control.

Schizophrenia Bulletin 35(1): 115-135.

111. Carter CS, Barch DM, Gur R, Gur R, Pinkham A, Ochsner K (2009). CNTRICS final task selection: Social cognitive and affective neuroscience-based measures. Schizophrenia Bulletin 35(1): 153-162.

112. Anderson JR, Carter CS, Fincham JM, Qin Y, Ravizza SM, Rosenberg-Lee M (2008). Using fMRI to test models of complex cognition. Cognitive Science. 32: 1323-1348.

9

Carter, C.S., curriculum vitae 9/2016 113. van Veen V, Krug MK, Carter CS (2008). The neural and computational basis of controlled speed-accuracy tradeoff during task performance. Journal of Cognitive Neuroscience 20(11): 1952-1965.

114. Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS (2008). Modafinil shifts human locus coeruleus to low-tonic, high phasic activity during functional MRI. Science 322(4908):1700-1702.

115. Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, Montrose D (2008). Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. American Journal of Psychiatry 165 ( 12): 1585-1593.

116. Ravizza SM, Anderson JR, Carter CS (2008). Errors in mathematical processing: The relationship of accuracy to neural regions associated with retrieval or representation of the problem state. Brain Research 1238: 118-1126.

117. Yoon JH, Tamir D, Minzenberg MJ, Ragland JD, Ursu S, Carter CS (2008). Multivariant pattern analysis of functional magnetic resonance imaging data reveals deficits in distributed representations in schizophrenia. Biological Psychiatry 64(12): 1035-1041.

118. Carter CS, Heckers S, Nichols T, Pine D, Strothers S (2008): Optimizing the design and analysis of clinical fMRI research studies. Biological Psychiatry 64(10):842-849.

119. Solomon M, Ozonoff S, Carter CS, and Caplan R (2008). Formal thought disorder and the autism spectrum: relationship with symptoms, executive control, and anxiety. Journal ofAutism Development and Disorders, 38(8): 1474-1484.

120. Becker TM, Kerns KG, Macdonald AW 3rct, and Carter CS (2008). Prefrontal dysfunction in first-degree relatives of schizophrenia patients during a Stroop task. Neuropsychopharmacology 33(11):2619-2625.

121. Ursu S, Clark KA, Stenger VA, Carter CS (2008). Distinguishing expected negative outcomes from preparatory control in the human orbitofrontal cortex. Brain Research 1227:110-119.

122. Ravizza SM, Carter CS (2008). Shifting set about task switching: Behavioral and neural evidence for distinct forms of cognitive flexibility. Neuropsychologia 46(12):2924-2935.

123. Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R (2008). Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biological Psychiatry 64(1):4-10. .

124. Barch DM, Carter CS (2008). The CNTRICS Executive Committee: Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: A report of the second consensus building conference of the CNTRICS initiative. Schizophrenia Bulletin 34(4):613-618.

125. Yoon JH, Minzenberg MJ, Ursu S, Walters R, Wendelken C, Ragland JD, Carter CS (2008): Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. American Journal of Psychiatry 165(8):1006-1014.

126. Minzenberg Mand Carter CS (2008). Modafinil: A review ofneurochemical effects and effects on cognition.

Neuropsychopharmacology 33(7): 1477-502.

127. Krystal JH, Carter CS, Geschwind D, Manji HK, March JS, et al (2008). It is time to take a stand for medical research and against terrorism targeting medical research. Biological Psychiatry 63(8):725-727.

128. Salo RE, Nordahl TE, Leamon MH, Natsuaki T, Moore CD, Waters C, Carter CS (2008). Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Research 157(1-3):273-277.

129. Solomon M, OzonoffSJ, Cummings N, Carter CS (2008). Cognitive control in autism spectrum disorders. International Journal ofDevelopmental Neuroscience 26(2):239-247.

130. Wendelken C, Nakhabenko D, Donohue SE, Carter CS, Bunge SA (2008). Brain is to thought as stomach is to??. Journal of Cognitive Neuroscience 20(4):682-683.

131. Wendelken C, Bunge SA, Carter CS (2008). Maintaining structured information: An investigation into functions of parietal and lateral prefrontal cortices. Neuropsychologia 46(2):665-678.

132. Wagner A, Aizenstein H, Venkatraman VK, Fudge J, May JC, Mazurkewicz L, Frank GK, Bailer UF, Fischer L, Nguyen V, Carter CS, Putanm K, Kaye WH (2007). Altered reward processing in women recovered from anorexia nervosa. American Journal of Psychiatry 164(12):1842-1849.

10

Carter, C.S., curriculum vitae 9/2016 133. Carter CS, van Veen V (2007). Anterior cingulate and conflict detection: An update of theory and data. Cognitive, Affective and Behavioral Neuroscience, 7(4)367-379.

134. Ladouceur CD, Dahl RE, Carter CS (2007). Development ofaction monitoring through adolescence into adulthood: ERP and source localization. Develpmental Science 10(6):874-191.

135. Ragland JD, Yoon JY, Minzenberg MJ, Carter CS (2007). Neuroimaging of cognitive disability in schizophrenia: Search for a pathophysiological model. International Review of Psychiatry 19(4):417-427.

136. Carter CS and Barch D (2007). Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: The CNTRlCS initiative. Schizophrenia Bulletin, 33(5)1131-1137.

137. Minzenberg Mand Carter CS (2007). The quest for developing new treatments from imaging techniques: promises, problems and future potential. Expert Opinion in Drug Discovery 2: 1029-1033.

138. Goghari VM, Rehm K, Carter CS, MacDonald III AM (2007). Sulcal thickness as a vulnerability factor for schizophrenia.

British J Psychiatry 191:229-233.

139. Carter CS (2007). Some rewarding insights into the cognitive and neurobiological basis of negative symptoms in schizophrenia.

Biological Psychiatry 62(7):709-710.

140. Sohn MH, Albert MV, Jung K, Carter CS, Anderson JR (2007). Anticipation of conflict monitoring in the anterior cingulate cortex and the prefrontal cortex. Proceedings of the National Academy ofSciences of the US.A. 104(25):10330-10334.

141. Ravizza SM, Robertson LC, Carter CS, Nordahl TE, Salo RE (2007). Is filtering difficulty the basis of attentional deficits in schizophrenia? Psychiatry Research 151 (3): 201-209.

142. MacDonald III AW, Carter CS, Flory JD, Ferrell RE, Manuck SB (2007). COMT Vall58Met and executive control: a test of the benefit of specific deficits in translational research. Journal ofAbnormal Psychology 116(2): 306-312.

143. Brambilla P, MacDonald AW, Sassi RM, Johnson MK, Mallinger AG, Carter CS, Soares JC (2007). Context processing in bipolar disorder patients. Bipolar Disorders 9(3):230-237.

144. Anderson JR, Qin Y, Jung, K-J, Carter CS (2007). Information-processing modules and their relative modality specificity.

Cognitive Psychology 54: 185-217.

145. Siegle GH, Thompson W, Carter CS, Steinhauer SR, Thase ME (2007). Increased amygdale and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biological Psychiatry 61(2):198-209.

146. Goghari VM, Rehm K, Carter CS, MacDonald AW 3rd (2007). Regionally specific cortical thinning and gray matter_

abnormalities in the healthy relatives of schizophrenia patients. Cerebral Cortex 17(2):415-424.

147. Wu M, Rosano C, Lopez-Garcia P, Carter CS, Aizenstein HJ (2007). Optimum template selection for atlas-based sementation.

Neurolmage 34(4):1612-1618.

148. Van Veen V and Carter CS (2006). Error detection, correction, and prevention in the brain: a brief review of data and theories.

Clinical EEG Neuroscience 37(4)330-335.

149. Cho RY, Konecky RO, Carter CS (2006). Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proceedings of the National Academy ofSciences of the US.A. 103(52)19878-19883.

150. Van Veen V and Carter CS (2006). Conflict and cognitive control in the brain. Current Directions in Psychological Science 15(5):237-240.

151. Yoon JH, D'Esposito M, and Carter CS (2006). Preserved function of the fusiform face area in schizophrenia as revealed by tMRI. Psychiatry Research Neuroimaging 148(2-3)205-216.

152. MacDonald AW, Becker T, Carter CS (2006). Functional MRI study in cognitive control deficits in the healthy relatives of schizophrenia patients. Biological Psychiatry 60(11): 1241-1249.

153. Lopez-Garcia P, Aizenstein HJ, Snitz BE, Walter RP, Carter CS (2006). Automated ROI-based brain parcellation analysis of frontal and temporal brain volumes in schizophrenia. Psychiatry Research Neuroimaging 147: 153-161.

154. Carter CS (2006). Re-conceptualizing schizophrenia as a disorder of cognitive and emotional processing: a shot in the arm for translational research. Biological Psychiatry 60(11): 1169-1170.

155. Wu M, Carmichael 0, Lopez-Garcia P, Carter CS, Figurski JL, Aizenstein HJ (2006). Quantitative comparison of AIR, SPM, and the fully deformable model for atlas-based segmentation of functional and structural MR images. Human Brain Mapping 27(9): 747-754.

11

Carter, C.S., curriculum vitae 9/2016 156. Forbes EE, May CJ, Siegle GJ, Ladouceur CD, Ryan ND, Carter CS, Birmanher B, Axelson DA, Dahl RE (2006). Reward-related decision- making in pediatric major depressive disorder: an fMRI study. Journal of Child Psychology and Psychiatry 47(10)1031-1040.

157. Aizenstein HJ, Butters MA, Clark KA, Figurski JL, Stenger AV, Nebes RD, Reynolds CF III, Carter CS (2006). Prefrontal and striatal activation in elderly subjects during concurrent implicit and explicit sequence learning. Neurobiology ofAging 27(5):741-751.

158. Siegle GJ, Carter CS, Thase ME (2006). Use ofFMRI to predict recovery from unipolar depression with cognitive behavior therapy. American Journal of Psychiatry 163(4):735-738.

159. Snitz BE, Macdonald AW III, Carter CS (2006). Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophrenia Bulletin 32(1): 179-194.

160. Carter CS (2006). Understanding the glass ceiling for functional outcome in schizophrenia. American Journal of Psychiatry 163(3):356-358.

161. Carter CS, Pine DS (2006). Polishing the windows of the mind. American Journal of Psychiatry 163(5): 761-763.

162. Frank GK, Wagner A, Achenbah S, McConaha C, Skovira K, Aizenstein H, Carter CS, Kay WH (2006). Altered brain activity in women recovered from bulimic-type eating disorders after a glucose challenge: a pilot study. International Journal of Eating Disorders 39(1)76-79.

163. Carter CS (2005). Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia. Schizophrenia Bulletin 31: 810-815.

164. Cho RY, Ford JM, Krystal JH, Laruelle M, Cuthbert B, Carter CS (2005). Functional neuroimaging and electrophysiological biomarkers for clinical trials for cognition in schizophrenia. Schizophrenia Bulletin 31:865-869.

165. MacDonald III AG, Goghari VM, Hicks BM, Flory JD, Carter CS, Manuck SB (2005). A convergent-divergent approach to context processing, general intellectual functioning and genetic liability in schizophrenia. Neuropsychology 19:814-821.

166. Rosano C, Aizenstein J, Cochran J, Saxton J, DeKosky S, Newman AB, Kuller LH, Lopez OL, Carter CS (2005). Functional neuroimaging indicators of successful executive control in the oldest old. Neurolmage 28:881-889.

167. Snitz BE, MacDonald A, Cohan JD, Cho RY, Becker T, Carter CS (2005). Lateral and medial hypofrontality in first episode schizophrenia: functional activity in medication-naive state and effects of short term atypical anti psychotic treatment. American Journal of Psychiatry 162:2322-2329.

168. Kerns JG, Cohen JD, MacDonald AW, Johnson MK, Stenger VA, Aizenstein H, Carter CS (2005). Decreased Conflict and Error-Related Activity in the Anterior Cingulate Cortex in Schizophrenia. American Journal ofPsychiatry 162: 1833-1839.

169. vanVeen V, Carter CS (2005). Separating semantic conflict and response conflict in the Stroop task: A functional MRI study.

Neuroimage 27:497-504.

170. Rosano C, Aizenstein HJ, cochran JL, Saxton JA, DeKosky ST, Newman AB, Kuller LH, Lopez OL, Carter CS (2005). Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment. Biological Psychiatry 57: 761-767.

171. Barch DM, Carter CS (2005). Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers. Schizophrenia Research. 77:43-58.

172. McGurk SR, Carter CS, Goldman R, Green MF, Marder SR, Xie H, Schooler NR, Kane JM (2005). The effects of clozapine and risperidone on spatial working memory in schizophrenia. American Journal of Psychiatry 16: 1013-1016.

173. Holmes AJ, MacDonald III A, Carter CS, Barch DM, Stenger VA, Cohen JD (2005). Prefrontal functioning during context processing in schizophrenia and major depression: An event-related fMRI study. Schizophrenia Research 76:199-206.

174. Barber AD, Carter CS (2005). Cognitive Control Involved in Overcoming Prepotent Response Tendencies and Switching Between Tasks. Cerebral Cortex 15:899-912.

175. MacDonald AW III, Carter CS, Kerns JG, Ursu S, Barch D, Holmes AJ, Stenger VA, Cohen JD (2005). Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis.

American Journal ofPsychiatry, 162(3):475-484.

176. Ursu S, Carter CS, (2005). Outcome representations, counterfactual comparisons and the human orbitofrontal cortex:

implications for neuroimaging studies of decision-making. Cognitive Brain Research 23(1):51-60.

12

Carter, C.S., curriculum vitae 9/2016 177. Sohn MH, Goode A, Stenger A, Jung KJ, Carter CS, Anderson JR (2005). An information-processing model of three cortical regions: evidence in episodic memory retrieval. Neurolmage 25(1):21-33.

178. Rosano C, Becker J, Lopez 0, Lopez-Garcia P, Carter CS, Newman A, Kuller L, Aizenstein H (2005). Morphometric Analysis of Gray Matter Volume in Demented Older Adults: Exploratory Analysis of the Cardiovascular Health Study Brain MRI Database. Neuroepidemiology 24(4):221-229.

179. Barch DM, Carter CS, Cohen JD (2004). Factors influencing Stroop performance in schizophrenia. Neuropsychology 18:477-484.

180. Botvinick MM, Cohen JD, Carter CS (2004). Conflict monitoring and anterior cingulated cortex: an update. Trends in Cognitive Sciences 8 (12):539-546.

181. Rogers RD, Ramnani N, Mackay C, Wilson JL, Jezzard P, Carter CS, Smith SM (2004). Distinct portions ofanterior cingulate cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition.

Biological Psychiatry 55(6):594-602.

182. RidderinkhofKR, van den Wildenberg WPM, Segalowitz SJ, Carter CS (2004). Neurocognitive mechanisms of cognitive control: The role ofprefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain and Cognition 56(2): 129-140.

183. Sohn MH, Goode A, Kodeigner KR, Stenger FA, Fissell K, Carter CS, Anderson JR (2004). Behavioral Equivalence, But Not Neutral Equivalence: Neural Evidence in Alternative Strategies in Mathematical Thinking. Nature Neuroscience 7(11): 193-1194.

184. Nofzinger EA, Buysse DJ, Germain A, Carter CS, Luna B, Price JC, Meltzer CC, Miewald JM, Reynolds CF, Kupfer DJ (2004 ). Increased activation of anterior paralimbic and executive cortex from waking to rapid eye movement sleep in depression.

Archives of General Psychiatry 61:695-701.

185. Kerns JG, Cohen JD, Stenger VA, Carter CS (2004). Prefrontal cortex guides context-appropriate responding during language production. Neuron 43(2):283-291.

186. vanVeen V, Holroyd CB, Cohen JD, Stenger VA, Carter CS (2004). Errors without conflict: implications for performance monitoring theories of anterior cingulated cortex. Brain and Cognition 56(2):267-276.

187. Aizenstein HJ, Clark KA, Butters MA, Cochran JL, Stenger VA, Meltzer CC, Reynolds CF, 3rd, Carter CS (2004). The BOLD hemodynamic response in healthy aging. Journal of Cognitive Neuroscience 16 (5):786-793.

188. Qin Y, Carter CS, Silk EM, Stenger VA, Fissell K, Goode A, Anderson JR (2004). The change of the brain activation patterns as children learn algebra equation solving. Proceedings of the National Academy of Sciences, US.A. 101(15): 5686-5691.

189. Anderson JR, Qin Y, Stenger VA, Carter CS (2004). The relationship of three cortical regions to an information-processing model. Journal of Cognitive Neuroscience 16(4):637-653.

190. Kerns JG, Cohen JD, MacDonald AW, III, Cho R., Stenger VA, Carter CS (2004). Anterior cingulate conflict monitoring and adjustments in control. Science 303:1023-1026.

191. May JC, Delgado MR, Dahl RE, Stenger VA, Ryan ND, Fiez JA, Carter CS (2004). Event-related functional magnetic resonance imaging ofreward-related brain circuitry in children and adolescents. Biological Psychiatry 55(4):359-366.

192. Aizenstein H, Stenger V, Cochran J, Clark KA, Johnson M, Nebes R, Carter CS (2004). Regional brain activation during concurrent implicit and explicit sequence learning. Cerebral Cortex 14(2): 199-208.

193. Frank GK, Kaye WH, Carter CS, Brooks S, May C, Fissell K, Stenger VA (2003). The evaluation of brain activity in response to taste stimuli-a pilot study and method for central taste activation as assessed by event-related fMRI. Journal of Neuroscience Methods 131(1-2):99-105.

194. MacDonald AW, Carter CS (2003). Event-related fMRl study of context processing in dorsolateral prefrontal cortex of patients with schizophrenia. Journal ofAbnormal Psychology 112(4):689-697.

195. Anderson JR, Qin Y, Sohn MH, Stenger AV, Carter CS (2003). An information-processing model of the BOLD response in symbol manipulation tasks. Psychonomic Bulletin & Review 10(2):241-261.

196. Siegle G, Steinhauer S, Stenger VA, Konecky RO, Carter CS (2003) Use of concurrent pupil dilatation to inform interpretation and analysis offMRI data. Neurolmage 20:114-124 13

______ I

Carter, C.S., curriculum vitae 9/2016 197. Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS (2003). Overactive action monitoring in obsessive-compulsive disorder:

Evidence from functional magnetic resonance imaging. Psychological Science 14(4):347-353.

198. Rogers R, Tumbridge E, Bagwagar Z, Drevets W, Sahakian B, Carter CS (2003) Tryptophan depletion alters the decision making of healthy volunteers through altered processing ofreward cues. Neuropsychopharmacolog 28: 153-162.

199. Siegle GJ, Steinhauer SR, Carter CS, Ramel W, Thase ME (2003). Do the seconds tum into hours? Relationships between sustained dilation in response to emotional information and self-reported rumination. Cognitive Therapy and Research 27(3):365-382.

200. Sohn M-H, Goode A, Stenger, VA, Carter CS, Anderson JR (2003). Competition and representation during memory retrieval:

Roles of the prefrontal cortex and the posterior parietal cortex. Proceedings of the National Academy ofSciences of the US.A.

JOO (12):7412-7417.

201. Macdonald A, Pogue-Guille M, Johnson MK, Carter CS (2003). A specific context processing deficit in the unaffected relatives of schizophrenia patients Archives of General Psychiatry 60:57-65.

202. Qin Y, Sohn M-H, Anderson J, Stenger VA, Goode A, Carter CS (2003). Predicting the practice effects on the blood oxygenation level-dependent (BOLD) function offMRl in a symbolic manipulation task. Proceedings of the National Academy of Sciences of the US.A. 100(8):4951-4956.

203. Barch DM, Carter CS, Macdonald A, Cohen JD (2003). Context processing deficits in schizophrenia: Diagnostic specificity, 4-week course and relationship to clinic symptoms. Journal ofAbnormal Psychology 112: 132-143.

204. Perlstein WM, Dixit, NK, Carter CS, Noll DC, Cohen JD (2003). Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biological Psychiatry 53:25-38.

205. Fissell K, Tseylin E, Cunningham D, Carter CS, Schneider W, Cohen JD (2003). Fiswidgets: A Graphical Computing Environment for Neuroimaging Analysis. Neuroinformatics 1: 111-125.

206. Tamminga CA, NemeroffCB, Blakely RD, Brady L, Carter CS, Davis KL, Dingledine R, Gorman JM, Grigoriadis D, Henderson D, Innis R, Killen J, Langhren TP, McDonald WM, Murphy G, Paul SM, Rudorfer M, Sausville E, Schatzberg A, Scolnick E, Suppes T (2002). Developing novel treatments for mood disorders: accelerating discovery. Biological Psychiatry 52(6):589.609.

207. MacDonald AW, III, Carter CS (2002). Cognitive experimental approaches to investigating impaired cognition in schizophrenia: a paradigm shift. Journal of Clinical and Experimental Neuropsychology, 24(7):873-882.

208. vanVeen V, Carter CS (2002). The anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiology & Behavior 77 (4-5): 477-482.

209. van Veen V, Carter CS (2002). The timing of action monitoring processes in the anterior cingulate cortex. J Cognitive Neuroscience 14(4):593-602.

210. Fincham J, Carter CS, vanVeen V, Stenger VA, Anderson J (2002). Neural basis of planning: an event related fMRl study.

Proceedings of the National Academy ofSciences of the US.A. 99:3346-3351.

211. Henik, A, Carter CS, Salo RE, Chaderjian M, Kraft L, Norhahl, TE, Robertson LC (2002). Attentional control and word inhibition in schizophrenia. Psychiatry Research 110: 13 7-149.

212. Aizenstein H, Nebes R, Meltzer C, Fukui M, Williams R, Saxton J, Houck P, Carter CS, Reynolds C, III, DeKosky S (2002).

The relation of white matter hyperintensities to implicit learning in healthy older adults. international Journal of Geriatric Psychiatry, 17(7):664-9.

213. Ganguli R, Singh A, Brar J,Carter C, Mintun M (2002). Hydrocortisone induced regional cerebral activity changes inn schizophrenia: a PET scan study. Schizophrenia Research 56:241-247.

214. Siegle GJ, Steinhauer SR, Thase ME, Stenger VA, Carter CS (2002). Can't shake that feeling: fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biological Psychiatry. 51 :693-707.

215. Carter CS, MacDonald AW, Ross LL, Stenger AS (2001). Anterior Cingulate Cortex and Impaired Self-Monitoring of Performance in Patients with Schizophrenia: An Event-Related fMRI Study. American Journal of Psychiatry 158: 1423-1428.

216. Braver TS, Barch DM, Keys BA, Carter CS, Cohen JD, Kaye JA, Janowsky JS, Taylor SF, Yesavage JA, Mumenthaler MS, Jagust WJ, Reed BR (2001). Context processing in older adults: Evidence for a theory relating cognitive control to neurobiology in healthy aging. Journal ofExperimental Psychology:General 130:746-63.

14

Carter, C.S., curriculum vitae 9/2016 217. vanVeen V, Cohen JD, Botvinick MM, Stenger VA, Carter CS (2001). Anterior cingulate cortex, conflict monitoring, and levels of processing. Neurolmage 14(6): 1302-1308.

218. Nordahl TE, Carter CS, Salo RE, Kraft L, Baldo J, Salamat S, Robertson L, Kusubov N (2001). Anterior cingulate metabolism correlates with Stroop errors in paranoid schizophrenic patients. Neuropsychopharmacology 25(1):139-148.

219. Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD (2001). Conflict monitoring and cognitive control. Psychological Review. 108(3):624-52.

220. Perlstein WM, Carter CS, Noll DC, Cohen JD (2001). Relation of Prefrontal Cortex Dysfunction to Working Memory and Symptoms in Schizophrenia. American Journal of Psychiatry 158(7): 1105-1113.

221. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, Noll DC, Cohen JD (2001). Selective Deficits in Prefrontal Cortex Function in Medication Naive Patients with Schizophrenia. Archives of General Psychiatry 58:280-288.

222. Cohen JD, Botvinick M, Carter CS (2000). Anterior cingulate and prefrontal cortex: who's in control? Nature Neuroscience 3(5):421-423.

223. Sohn MH, Ursu S, Anderson J, Stenger VA, Carter CS (2000). The role ofprefrontal cortex and posterior parietal cortex in task switching. Proceedings of the National Academy a/Sciences of the USA 97:13448-13453.

224. MacDonald AW, Cohen JD, Stenger VA, Carter CS (2000). Dissociating the role ofDorsolateral Prefrontal and Anterior Cingulate Cortex in cognitive control. Science 288:1835-1838.

225. Carter CS, MacDonald AM, Ross LL, Stenger VA, Noll D, Cohen JD (2000). Parsing executive processes: strategic versus evaluative functions of the anterior cingulate cortex. Proceedings of the National Academy a/Sciences of the U.S.A. 97:1944-1948.

226. Aizenstein HJ, MacDonald AW, Stenger VA, Nebes RD, Larson JK, Ursu S, Carter CS (2000). Complementary category learning systems identified using event-related functional MRI. Journal of Cognitive Neuroscience 12(6):977-987.

227. Carter CS, Botvinick MM, Cohen JD (1999). The Contribution of the Anterior Cingulate Cortex to Executive Processes in Cognition. Reviews in the Neurosciences 10:49-57.

228. Botvinick MM, Nystrom L, Fissell K, Carter CS, Cohen JD (1999). Conflict monitoring versus selection for action in anterior cingulate cortex. Nature 402(6758):179-181.

229. Barch DM, Sabb FW, Carter CS, Braver TS, Noll DC Cohen JD (1999). Overt Verbal Responding During FMRI Scanning:

Empirical Investigations of problems and Potential Solutions. Neurolmage 10(6):642-657.

230. Coley KC, Carter CS, DaPos SV, Maxwell R, Wilson JW, Branch RA (1999). Efficiency ofantipsychotic therapy in a naturalistic setting: A comparison between risperidone, perphenazine, and haloperidol. Journal a/Clinical Psychiatry 60(12):850-856.

231. Barch DM, Carter CS, Hachten PC, Usher M, Cohen JD (1999). The benefits of distractibility: mechanisms underlying increased Stroop effects in schizophrenia. Schizophrenia Bulletin 24(4):749-762.

232. Isoardi RA, Townsend DW, Carter CS, Herbster A, Dachille M, Meltzer C (1999). A study of injected dose for brain mapping on the ECAT HR+; activation maps for a parametric working memory task. Neurolmage 9: 145-153.

233. Cohen JD, Barch DM, Carter CS, Servan-Schreiber D (1999). Context processing deficits in schizophrenia: Converging evidence from three theoretically motivated cognitive tasks. Journal ofAbnormal Psychology 108:120-133.

234. Keshavan MS, Carter CS, Haas G, Schooler N (1999). Schizophreniform disorder: Exception proves the rule. American Journal ofPsychiatry 156:971-972.

235. Barch DM, Carter CS, Perlstein WM, Baird JD, Cohen JD, Schooler, N (1999). Increased Stroop facilitation is not due to enhanced spreading activation in schizophrenia. Schizophrenia Research 39(1):51-64.

236. Carter CS, Braver TS, Barch DM, Botvinick M, Noll D, Cohen JD (1998). Anterior Cingulate Cortex, Error Detection, and the On Line Monitoring of Performance. Science 280(5364):747-749.

237. Carter CS, Perlstein WM, Ganguli R, Brar J, Nichols T, Mintun M, Cohen JD (1998). Functional hypofrontality and working memory dysfunction in schizophrenia. American Journal of Psychiatry 155: 1285-1287.

238. Barch DM, Carter CS (1998). Selective attention in schizophrenia: relationship to verbal working memory. Schizophrenia Research 33:53-61.

15

Carter, C.S., curriculum vitae 9/2016 239. Perlstein, WM, Carter CS, Barch DM, Baird J (1998). The Stroop Task and Attention Deficits in Schizophrenia: A Critical Analysis of Card and Single Trial Methodologies, Neuropsychology 12(3):414-425.

240. Servan-Schreiber D, Carter CS, Bruno R, Cohen JD (1998). Dopamine and the Mechanisms of Cognition. Part II: D-Amphetamine Effects in Human Subjects Performing a Selective Attention Task. Biological Psychiatry 43: 713-722.

241. Servan-Schreiber D., Bruno R., Carter CS, Cohen JD (1998). Dopamine and the Mechanisms of Cognition. Part I: A Neural Network Model Predicting Dopamine Effects on Selective Attention. Biological Psychiatry 43:723-729.

242. Carter CS, Maddock RJ, Chaderjian M, Post R (1998). Attentional Effects of Single Dose Triazolam. Progress in Neuropsychopharmacology and Biological Psychiatry 22:279-292.

243. Maddock RJ, Carter CS, Tavano-Hall L, Amsterdam EA (1998). Hypocapnia associated with cardiac stress scintigraphy in chest pain patients with panic disorder. Psychosomatic Medicine 60:52-55.

244. Carter CS, Mintun M, Nichols T, Cohen JD (1997). Anterior Cingulate Gyms Dysfunction and Selective Attention Dysfunction in Schizophrenia: An 15 0-H2 0 PET Study During Stroop Task Performance. American Journal of Psychiatry 154: 1670-1675.

245. Ganguli R, Carter CS, Mintun M, Brar JS, Becker JT, Sarma TN, Bennington, E (1997). PET Brain Mapping Study of Auditory Verbal Supraspan Memory versus Visual Fixation in Schizophrenia Biological Psychiatry 41: 33-42.

246. Nordahl TE, Kusubov N, Carter CS, Salama S, Cummings AM, O'Shora-Celaya L, Eberling J, Robertson LC, Huesman R, Jagust W, Budinger TF (1996). Temporal lobe glucose metabolic differences in medication free out-patients with schizophrenia via the PET 600. Neuropsychopharmacology 15:541-554.

247. Carter, CS, Robertson LC, Nordahl TE, Chaderjian M, Oshora-Celaya L (1996). Attentional and perceptual asymmetries in schizophrenia: further evidence for a left hemisphere deficit. Psychiatry Research 62: 111-119 248. Carter, CS, Robertson LC, Nordahl TE, Kraft L, Chaderjian M, Oshora-Celaya L (1996). Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biological Psychiatry 40:930-932.

249. Carter CS, Mintun M, Cohen JD (1995). Interference and facilitation effects during selective attention: an 0 15H 20 PET study during Stroop task performance. Neurolmage 2:264-272.

250. Carter CS, Mulsant B, Sweet R, Maxwell R, Coley K, Ganguli R, Branch R (1995). Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications. Psychopharmacology Bulletin 31: 719-725.

251. Carter CS, Krener P, Chaderjian M, Northcutt C, Wolfe V (1995). Abnormal processing ofirrelevant information in attention deficit hyperactivity disorder. Psychiatry Research 56:59-70.

252. Carter CS, Krener P, Chaderjian M, Northcutt C, Wolfe V (1995). Asymmetrical visual-spatial attentional performance in ADHD: evidence for a right hemispheric deficit. Biological Psychiatry 37:789-797.

253. Carter CS, Fawcett J, Hertzman M, Papp LA, Jones W, Patterson WM, Swinson RP, Weise CC, Maddock RJ, Denahan AQ, Liebowitz M (1995). Adinazolam - SR in panic disorder with agoraphobia: relationship of daily dose to efficacy. Journal of Clinical Psychiatry 56:202-210.

254. Carter CS, Robertson LC, Chaderjian MC, Nordahl TE (1994). Attentional asymmetry in schizophrenia; role of illness subtype and symptomatology, Progress in Neuropsychopharmacology and Biological Psychiatry 18: 661-683.

255. Carter CS, Maddock R, Zoglio M, Lutrin C, Jella S, Amsterdam E (1994). Panic disorder and chest pain; a study of cardiac stress scintigraphy patients. American Journal of Cardiology 74:296-298.

256. Davidson JRT, Beitman B, Carter CS, Greist JH, Haack DG, Krishnan KR, Lewis CP, Liebowitz MR, Maddock R, Sheridan AQ (1994). Adinazolam treatment of panic disorder with agoraphobia: a double blind study. Journal of Clinical Psychopharmacology 14:255-263.

257. Beitman BD, Beck NC, Deuser WE, Carter CS, Davidson JRT, Maddock RJ (1994). Patient stage ofchange predicts outcome in a panic disorder medication trial. Anxiety 1:64-69.

258. Carter CS, Robertson LC, Nordahl TE, O'Shora-Celaya LJ, Chaderjian MC (1993). Abnormal processing of irrelevant information in schizophrenia: role of illness subtype. Psychiatry Research 48: 17-26.

259. Maddock RJ, Casson EJ, Lott LA, Carter CS, Johnson CA (1993). Benzodiazepine effects on flicker sensitivity: role of stimulus frequency and size. Progress in Neuropsychopharmacology and Biological Psychiatry 17:955-970.

16

Carter, C.S., curriculum vitae 9/2016 260. Maddock RJ, Carter CS, Magliozzi JR, Geitzen DW (1993). Evidence that decreased function oflymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia. American Journal of Psychiatry 150(8): 1219-1225.

261. Maddock RJ, Carter CS, Blacker KH, Beitman BD, Ranga Raura Krishnan K, Greist J, Lewis CP, Leibowitz MR (1993).

Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia.

Journal of Clinical Psychiatry 54:88-95.

262. Carter CS, Robertson L, Chaderjian M, Celaya L, Nordahl TE (1992). Attentional asymmetry in schizophrenia: controlled and automatic processes. Biological Psychiatry 31:909-918.

263. Carter CS, Robertson LC, Nordahl TE (1992). Abnormal processing of irrelevant information in schizophrenia: selective enhancement of Stroop facilitation. Psychiatry Research 41: 13 7-146.

.264. Carter CS, Maddock RJ and Magliozzi J (1992). The specificity of biased information processing in panic disorder and major depression. Psychopathology 25:65-70.

265. Carter CS, Maddock RJ, McCormick S, Waters CW, Billett J, and Amsterdam E (1992). Panic Disorder and chest pain in the coronary care unit. Psychosomatics 33(3):302-309.

266. Carter CS, and Maddock RJ (1992). Chest pain in generalized anxiety disorder. International Journal of Psychiatry in Medicine 22(3):291-298.

267. Maddock RJ and Carter CS (1991). Hyperventilation Induced Panic Attacks in Panic Disorder with Agoraphobia. Biological Psychiatry 29(9):843-854.

268. Maddock RJ and Carter CS (1991). Hyperventilation and Excess Lactate Production in Panic Disorder with Agoraphobia.

Psychiatry Research 38:301-311 INVITED PAPERS AND CHAPTERS:

1. Pakyurek M, Yamal R, Carter CS (2013). Treatment of Psychosis in Children and Adolescents: A Review. American Academy of Pediatrics. Adolescent Medicine: State of the Art Reviews. Current Psychopharmacology for Psychiatric Disorders in Adolescents. August 2013, Volume 24, Number 2.

2. Krug MK, Carter CS (2012). Conflict control loop theory of cognitive control. In Mangun, G.R. (Ed). Neuroscience of attention: attentional control and selection. Oxford University Press, New York, NY.

3. Ravizza, SM, Mangun, GR, Carter CS (2009). The Neural Basis of Attention. In S. Wood, N. Allen, & C. Pantelis (Eds.), The Neuropsychology ofMental Illness (pp. 105-116), Cambridge: University Press.

4. Carter CS, Minzenberg M, Yoon J (2009). Schizophrenia. In: Berntson GG and Cacioppo JT (Eds.). Handbook of Neuroscience for the Behavioral Sciences, John Wiley and Sons, Inc.

5. Minzenberg M, Yoon J, Carter CS (2009). Functional Neuroimaging. In: Thaker GK and Carpenter WT (Eds.). The Year in Schizophrenia, Atlas Medical Publishing, Ltd.

6. Minzenberg M, Yoon J, Carter CS (2008). Schizophrenia. In Hales Rand Yudofsky S, Eds. Textbook of Clinical Psychiatry, American Psychiatric Publishing. *

7. Yoon J, Minzenberg M, Carter CS (2007). Functional Neuroimaging. In: Thaker GK and Carpenter WT (Eds.). The Year in Schizophrenia, Atlas Medical Publishing, Ltd.

8. Yoon J and Carter CS (2006). Schizophrenia. In Hales Rand Simon R, Eds. Textbook of Suicide Assessment and Management, American Psychiatric Press.

9. Liu Y, Teverovskiy L, Carmichael 0, Kikinis R, Shenton M, Carter CS, Stenger S, Davis S, Aizenstein H, Becker J, Lopez 0, Meltzer C, (2004). Discriminative MR Image Feature analysis for Automatic Schizophrenia and Alzheimer's Disease classification. Proceedings of the 7th Annual International Conference on Medical Image Computing and Computer Aided Intervention.

10. Carter CS, Cho RY (2004). Monitoring impairments in schizophrenia. In D. Barch (Ed.), Cognitive and Affective Neuroscience of Psychopathology, New York, NY. Oxford University Press.

17

,.

Carter, C.S., curriculum vitae 9/2016

11. Botvinick M, Braver TS, Yeung N, Ullsperger M, Carter CS, Cohen JD (2004). Conflict monitoring: computational and empirical studies. In: Posner, M. I. (Ed.), Cognitive Neuroscience ofAttention. New York, New York: Guilford Publications, 7:91-102.

12. vanVeen V, Carter CS (2003). Anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiology and Behavior.

13. Carter CS, Kerns JG, Cohen JD. Cognitive neuroscience: Bridging thinking and feeling to the brain and its implications for psychiatry. In Charney and Kandel Eds. The Neurobiology of Mental Illness, 14:180-189.

14. Carter CS, Ursu S. (2003). Cognitive deficits in schizophrenia. Jn Handbook of Medical Psychiatry, Gershon Sand Soares Z.,

Eds.

15. Siegle OJ, Konecky RO, Thase MT, Carter CS (2003). Relationships between amygdala volume and activity during emotional information processing in depressed and never depressed individuals: An fMRI investigation. Annals ofthe New York Academy of Science.

16. Carter CS (2001). Cognitive Neuroscience and Psychiatry: New Insights and Opportunities for Understanding the Neural Basis of Mental Disorders. Morihisa J, Phillips KA (Eds): Volume 20 Annual Review ofPsychiatry 2001 - Section JV "Brain imaging in Psychiatric Practice. New York, American Psychiatric Press.

17. Keshavan MS, Carter CS (2000). First episode schizophrenia: A phase specific approach to management. Primary Psychiatry 7(11):43-50.

18. Carter CS (2000). Images in Psychiatry: Executive processes and anterior Cingulate Cortex. American Journal ofPsychiatry 157:1 3.

19. Carter CS, Botvinick MM, Cohen JD (1999). The role of the anterior cingulate cortex in executive processes of cognition.

Reviews in the Neurosciences 10:49-57.

20. Carter CS and Barch DM (2000). Attention, memory and language disturbances in schizophrenia: characteristics and implications. Andrade C (ed): Advances in Psychiat1y. London/New Delhi: Oxford University Press, 3:45-72.

21. Carter CS, Mintun M, Cohen JD, Nichols T (1998). Anterior Cingulate Gyms Dysfunction And Selective Attention Dysfunction in Schizophrenia, Reply. American Journal of Psychiatry. (Letter)

22. Isoardi RA, Townsend DW, Carter CS, Herbster A, Dachille M (1998). Optimum activity levels of 15H20-water to map human brain function with the ECAT HR+. IEEE symposium and conference on nuclear physics and medical imaging.

23. Carter CS, Servan-Schreiber D, Pearlstein W (1997). Anxiety disorders and the normal coronary artery chest pain syndrome:

prevalence and pathophysiology. J. Clinical Psychiatry, 58:70-73.

24. Carter CS, Swift RM, Turnbull JM (1996). When are long term anxiolytics warranted? Patient Care 30: 165-177.

25. Carter CS, Robertson LC, Nordahl TE, Chaderjian M, Celaya L (1994) A cognitive neuropsychological approach to the neurobiology of symptoms in schizophrenia, Actualities Psychiatriques, 24:5-8.

26. Amsterdam EA, Carter CS, Holloway R, Schwenk TL (1994). Is it normal worry -- or pathologic anxiety? Patient Care, 28:26-29.

27. Carter CS, Holloway R, Schwenk TL (1994). Treating anxiety: A collaborative approach. Patient Care, 28:36-52.

28. Carter CS, Elkin GD and Vinogradov S (1997). Schizophrenia. Jn Introduction to Clinical Psychiatry: A Case-Based Approach.

First Edition, Appleton Lang, Stanford Connecticut.

29. Elkin GD and Carter CS (1997). Anxiety Disorders. In Introduction to Clinical Psychiatry: A Case-Based Approach. First Edition, Appleton Lang, Stanford Connecticut.

30. Elkin GD, Newman E, Carter CS, and Zalslav M (1997). Post Traumatic Stress Disorder. In Introduction to Clinical Psychiatry: A Case-Based Approach. First Edition, Appleton Lang, Stanford Connecticut.

BOOKS Carter CS and Dalley JW, Brain Imaging in Behavioral Science, Springer 2014 18

-- ..

Carter, C.S., curriculum vitae 9/2016 ACTIVE RESEARCH FUNDING 5R01MH059883-ll (Carter) NIMH 06/01/2013 - 06/01/2018 Pathophysiology of Cognitive Disability in Schizophrenia: Using flvl.RI and two cognitive tasks evaluating unique aspects of cognitive control and approach motivation we will test the hypothesis that during a first episode of psychosis both schizophrenia that bipolar disorder patients will show cognitive control deficits that in schizophrenia will remain as stable trait deficits during the first year of illness but that in Bipolar disorder will show substantial improvement with clinical remission. In contrast Bipolar Disorder patients will show an enhanced sensitivity to repeated rewards that will be stable across clinical states, while schizophrenia patients will show intact or reduced responses to incentives across the course of the first year of illness.

5R01MH084826-05 (Carter) NIMH 10/12/2013 - 10/01/2017 Cognitive Neuroscience Task Reliability and Clinical Application Consortium Behavioral tasks measuring the RDoC constructs of reward sensitivity and working memory capacity will be validated, optimized, and characterized psychometrically. Optimized measures and their psychometric characteristics will then be publically available for use in treatment development studies.

5R21MH099327-02 (Carter, Swaab Co-Pl's) 02/01/2013 - 02/01/2015 Cognitive Control and Language Impairments in Schizophrenia. We will use ERP's to test the hypothesis that the inability to integrate discourse level context leads to comprehension deficits that in tum are related to social and functional disability in schizophrenia.

5R01MH104235-02 (Carter) NIMH 09/01/2014 - 09/01/2018 Reducing Duration of Untreated Psychosis through Rapid Identification and Engagement in a controlled study within an established early psychosis specialty treatment program in Sacramento we will use a novel hand held device based screening approach as well as telemedicine enabled community based interventions we will seek to reduce the duration of untreated psychosis and improve outcomes in young people undergoing a first episode of psychotic illness.

2T32MH082174-06Al (Carter) NIMH Training Program in Basic Neuroscience 06/30/2014 - 06/30/2019 Provides support for pre-doctoral trainees in the UC Davis Neuroscience Graduate Group during their first year of general training.

HHSN2712012000071 (Carter) NIMH FAST-FS 08/01/2015 - 07/01/2015 (Contract to Research Foundation for Mental Health, Columbia University)

Development and execution of experimental medicine studies using imaging biomarkers to confirm target engagement for novel treatments for psychotic disorders.

1P50MH106438-01 (Carter) NIH/NIMH 04/01/2015 - 03/31/2020 UC Davis Conte Center Neuroimmune Mechanisms of Psychiatric Disorders The goal of the Conte Center is to test the hypothesis that maternal immune activation contributes to schizophrenia by altering immune molecules in the brains of offspring, which, in tum, alters cortical connectivity, function, and behavior during development.

19